USANA Health Sciences Inc. - 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 26, 1998, and the nine months ended on that date. USANA develops and manufactures nutritional, personal care, and weight management products distributed via a network marketing system. As of the period end, the company had approximately 110,000 current distributors and 22,000 Preferred Customers across the United States, Canada, Australia, and New Zealand. The company recently expanded into the Australia/New Zealand market (February 1998) and is preparing for operations in the United Kingdom (expected late Q4 1998).
Key Financial Metrics
| Metric (in thousands) | Q3 1998 | Q3 1997 | 9 Months 1998 | 9 Months 1997 |
|---|---|---|---|---|
| Net Sales | $32,123 | $22,873 | $89,200 | $61,573 |
| Gross Profit | $25,398 | $18,064 | $70,581 | $48,611 |
| Gross Margin | 79.1% | 79.0% | 79.1% | 79.0% |
| Net Earnings | $2,530 | $1,856 | $6,870 | $4,641 |
| Net Profit Margin | 7.9% | 8.1% | 7.7% | 7.5% |
| Diluted EPS | $0.18 | $0.14 | $0.49 | $0.35 |
| Cash & Equivalents | $3,281 | $2,608 (Year End) | $3,281 | $2,608 (Year End) |
| Working Capital | $7,763 | $4,569 (Year End) | $7,763 | $4,569 (Year End) |
| Operating Cash Flow (9mo) | $7,824 | $5,683 | ||
| Capital Expenditures (9mo) |
Note: All financial figures are in thousands. A 2-for-1 stock split occurred on August 3, 1998; historical data has been adjusted to reflect this.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 40.4% in Q3 and 44.9% for the nine months ended September 26, 1998, compared to the prior year. Approximately 90% of this growth was driven by increased unit sales.
- Distributor Base: The independent distributor base grew 34.1% to 110,000, with 67% of this growth attributed to the new Australia/New Zealand market.
- Expense Trends: Distributor incentives (the largest expense) increased 37.1% in Q3 but decreased as a percentage of sales to 44.6% (from 45.6%) due to a repricing strategy. Selling, general, and administrative (SG&A) expenses rose 56.9% in Q3, increasing as a percentage of sales to 20.9% due to infrastructure investments for international expansion.
- Profitability: Net earnings rose 36.3% in Q3 and 48.0% for the nine-month period. Profit margins remained relatively stable, with a slight decrease in Q3 (7.9% vs 8.1%) and a slight increase for the nine months (7.7% vs 7.5%).
Outlook, Risks, and Management Commentary
- International Expansion: The company is investing heavily in the United Kingdom, having spent $2.7 million on a facility in Milton Keynes. Operations are expected to commence in late Q4 1998. The company anticipates international sales will continue to grow as a percentage of total net sales.
- Liquidity: The company maintains a $5.0 million line of credit (unused as of period end) and believes cash from operations and existing balances are sufficient for the next 12 months. However, additional financing may be required for future expansion.
- Year 2000 Compliance: The company is assessing Year 2000 risks and is in the process of installing a new ERP system (expected completion Q2 1999) which is certified Year 2000 compliant. There is a risk of operational disruption if third-party providers fail to remediate their systems.
- Legal Proceedings: USANA is a defendant in a patent infringement lawsuit filed by International Nutrition Company regarding grape seed extract in its Proflavanol product. USANA filed a motion to dismiss in July 1998.
- Key Personnel: The company relies heavily on Dr. Myron Wentz (President, CEO, Chairman), who currently does not receive a salary. If he were to take a salary, SG&A expenses would increase.
Investor Verification Checklist
- Stock Split Adjustment: Verify that all historical share counts and EPS figures in external databases have been adjusted for the 2-for-1 split effective August 3, 1998.
- UK Expansion Costs: Monitor capital expenditure trends and the timeline for the commencement of UK operations to ensure the $2.7 million investment yields expected returns.
- Distributor Incentive Ratio: Track the "Distributor Incentives as a % of Net Sales" metric. While currently stable at ~44.8%, management notes this is a significant risk factor if the ratio rises.
- Year 2000 Readiness: Confirm the status of the ERP system installation and the compliance status of critical third-party vendors.
- Legal Status: Monitor the outcome of the motion to dismiss in the International Nutrition Company patent infringement case.